Cargando…

What is the intermediate host species of SARS-CoV-2?

Dissecting the published evidence on the intermediate host species of SARS-CoV-2. An editorial review of the proximal origins of SARS-CoV-2, what may have been missed and why it matters.

Detalles Bibliográficos
Autores principales:	Friend, Thomas, Stebbing, Justin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860928/ http://dx.doi.org/10.2217/fvl-2020-0390

Ejemplares similares

The Potential Intermediate Hosts for SARS-CoV-2
por: Zhao, Jie, et al.
Publicado: (2020)

Reducing transmission of SARS-CoV-2 with intranasal prophylaxis
por: Boiardi, Federico, et al.
Publicado: (2020)

SARS-CoV-2: Origin, Intermediate Host and Allergenicity Features and Hypotheses
por: Huang, Yuyi, et al.
Publicado: (2021)

Analysis of Possible Intermediate Hosts of the New Coronavirus SARS-CoV-2
por: Yuan, Shu, et al.
Publicado: (2020)

Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
por: Liu, Ping, et al.
Publicado: (2020)

SARS-CoV-2 (COVID-19) superspreader events
por: Majra, Dasha, et al.
Publicado: (2021)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Correction: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
por: Liu, Ping, et al.
Publicado: (2021)

Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury
por: Tabassum, Neha, et al.
Publicado: (2020)

What is Currently Known About the SARS-CoV2 Variants of Concern
por: Souaid, Tarek, et al.
Publicado: (2021)

SARS-CoV-2 pandemic in India: what might we expect?
por: Gautam, Sneha, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination: What Can We Expect Now?
por: Meurens, François, et al.
Publicado: (2022)

MERS-CoV: the intermediate host identified?
por: de Wit, Emmie, et al.
Publicado: (2013)

Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?
por: Prague, Mélanie, et al.
Publicado: (2022)

Sports balls as potential SARS-CoV-2 transmission vectors
por: Pelisser, Michel, et al.
Publicado: (2020)

SARS-CoV-2 infection among hospital workers. What about us?
por: Cuadros-González, Juan
Publicado: (2021)

SARS-CoV-2 infection among hospital workers. What about us?
por: Cuadros-González, Juan
Publicado: (2021)

What happened to non-SARS-CoV-2 respiratory diseases during the pandemic?
por: Maurici, Rosemeri
Publicado: (2023)

Application of a novel mathematical model to identify intermediate hosts of SARS-CoV-2
por: Royce, Katherine
Publicado: (2021)

Host cell membrane capture by the SARS-CoV-2 spike protein fusion intermediate
por: Su, Rui, et al.
Publicado: (2022)

Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate
por: Su, Rui, et al.
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

Body temperature and host species preferences of SARS-CoV-2
por: Uzoigwe, Chika Edward
Publicado: (2020)

SARS-CoV-2 vaccination in heart transplantation: What we do and do not know
por: Aslam, Saima, et al.
Publicado: (2022)

New Variants in SARS-CoV-2: What are we Learning from the Omicron Variant?
por: Galán, Juan Carlos, et al.
Publicado: (2022)

Thrombotic complications of vaccination against SARS-CoV-2: what pharmacovigilance reports tell us – and what they don't
por: Konstantinides, Stavros V.
Publicado: (2021)

Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022)

Viral CpG Deficiency Provides No Evidence That Dogs Were Intermediate Hosts for SARS-CoV-2
por: Pollock, David D, et al.
Publicado: (2020)

Special Issue “Viral and Host Factors Driving the Emergence and the Evolution of the SARS-CoV-2 and Other Coronaviruses”
por: Ronfort, Corinne
Publicado: (2022)

SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps
por: Sigler, Rachel, et al.
Publicado: (2022)

The SARS-CoV-2, tears, and ocular surface debate: What we know and what we need to know
por: Ali, Mohammad Javed
Publicado: (2020)

Origins of SARS-CoV-2: Focusing on Science
por: Shi, Zheng-Li
Publicado: (2021)

SARS-CoV-2 and its infected world
Publicado: (2021)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Diabetes mellitus and SARS-CoV-2 infection()
por: Alonso, Núria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j5rbblvonopp46mmgjodueu8al